Tucker Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.3M Sell
511,064
-500,000
-49% -$9.01M 2.54% 6
2026
Q2
$17.5M Hold
1,011,064
– – 4.32% 6
2026
Q1
$12.6M Hold
1,011,064
– – 3.76% 6
2025
Q4
$12.7M Sell
1,011,064
-100,000
-9% -$1.14M 3.71% 6
2025
Q3
$11.1M Hold
1,111,064
– – 3.35% 7
2025
Q2
$8.99M Hold
1,111,064
– – 2.87% 7
2025
Q1
$9.31M Hold
1,111,064
– – 3.02% 7
2024
Q4
$8.8M Hold
1,111,064
– – 0.94% 11
2024
Q3
$9.24M Hold
1,111,064
– – 2.13% 11
2024
Q2
$7.06M Buy
+1,111,064
New +$7.05M 1.54% 14

Other funds holding AMRX

Tucker Asset Management's AMRX Position: Q3 2026 in Review

Tucker Asset Management reduced its Amneal Pharmaceuticals (AMRX) stake by 49% in Q3 2026, selling an estimated $9.01M and leaving 511,064 shares worth $10.3M. The position accounts for 2.54% of the portfolio, ranked #6.

Tucker Asset Management first reported a position in AMRX in Q2 2024 and has held it in 10 quarters since. The position peaked at $17.5M in Q2 2026. 273 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • Tucker Asset Management held 511,064 shares of Amneal Pharmaceuticals worth $10.3M as of Q3 2026.
  • Tucker Asset Management sold 500,000 Amneal Pharmaceuticals shares in Q3 2026, an estimated $9.01M.
  • Amneal Pharmaceuticals made up 2.54% of Tucker Asset Management's portfolio in Q3 2026, its #6 holding.
  • Tucker Asset Management first reported a position in Amneal Pharmaceuticals in Q2 2024 and has held it in 10 quarters since.
  • Tucker Asset Management's Amneal Pharmaceuticals position peaked at $17.5M in Q2 2026.
  • 273 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on Tucker Asset Management's 13F filing for Q3 2026, filed 29 Oct 2026.